FWP 1 d820177dfwp.htm PRICING SHEET Pricing Sheet
LOGO   

November 2014

Pricing Sheet dated November 7, 2014 relating to

Preliminary Terms No. 237 dated November 3, 2014

Registration Statement No. 333-177923

Filed pursuant to Rule 433

STRUCTURED INVESTMENTS

Opportunities in U.S. Equities

PLUS Based on the Value of the S&P 500® Index due December 10, 2015

Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

 

  PRICING TERMS — November 7, 2014
  Issuer:    JPMorgan Chase & Co.
  Underlying index:    S&P 500® Index
  Aggregate principal amount:    $2,045,500
  Payment at maturity:    If the final index value is greater than the initial index value, for each $10 stated principal amount PLUS,
  

$10 + leveraged upside payment

  

In no event will the payment at maturity exceed the maximum payment at maturity.

   If the final index value is less than or equal to the initial index value, for each $10 stated principal amount PLUS,
  

$10 × index performance factor

  

This amount will be less than or equal to the stated principal amount of $10 per PLUS.

  Leveraged upside payment:    $10 × leverage factor × index percent increase
  Index percent increase:    (final index value – initial index value) / initial index value
  Initial index value:    The index closing value of the underlying index on the pricing date, which was 2,031.92
  Final index value:    The index closing value of the underlying index on the valuation date
  Leverage factor:    200%
  Index performance factor:    final index value / initial index value
  Maximum payment at maturity:    $11.075 (110.75% of the stated principal amount) per PLUS
  Stated principal amount:    $10 per PLUS
  Issue price:    $10 per PLUS (see “Commissions and issue price” below)
  Pricing date:    November 7, 2014
  Original issue date (settlement   date):    November 13, 2014
  Valuation date:    December 7, 2015, subject to postponement in the event of certain market disruption events and as described under “Description of PLUS — Postponement of a Determination Date” in the accompanying product supplement no. MS-1-III
  Maturity date:    December 10, 2015, subject to postponement in the event of certain market disruption events and as described under “Description of PLUS — Payment at Maturity” in the accompanying product supplement no. MS-1-III
  CUSIP / ISIN:    48127P705 / US48127P7050
  Listing:    The PLUS will not be listed on any securities exchange.
  Agent:    J.P. Morgan Securities LLC (“JPMS”)

Commissions and issue price:

 

Price to public(1)

 

Fees and commissions

 

Proceeds to issuer

            Per PLUS

  $10.00   $0.175(2)   $9.775
    $0.05(3)  

            Total

  $2,045,500.00   $46,023.75   $1,999,476.25
  (1) See “Additional Information about the PLUS — Use of proceeds and hedging” in the accompanying preliminary terms for information about the components of the price to public of the PLUS.
  (2) JPMS, acting as agent for JPMorgan Chase & Co., will pay all of the selling commissions of $0.175 per $10 stated principal amount PLUS it receives from us to Morgan Stanley Smith Barney LLC (“Morgan Stanley Wealth Management”). See “Underwriting (Conflicts of Interest)” beginning on page PS-69 of the accompanying product supplement no. MS-1-III.
  (3) Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $0.05 for each $10 stated principal amount PLUS

The estimated value of the PLUS on the pricing date as determined by JPMS was $9.729 per $10 stated principal amount PLUS. See “Additional Information about the PLUS — JPMS’s estimated value of the PLUS” in the accompanying prelminary terms for additional information.

The PLUS are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.

You should read this document together with the preliminary terms describing the offering and the related product supplement no. MS-1-III, underlying supplement no. 1-I, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see “Additional Information about the PLUS” in the accompanying preliminary terms.

Preliminary terms no. 237 dated November 3, 2014: http://www.sec.gov/Archives/edgar/data/19617/000119312514394348/d815097dfwp.htm

Product supplement no. MS-1-III dated March  18, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214002102/e57956_424b2.pdf

Underlying supplement no. 1-I dated November  14, 2011: http://www.sec.gov/Archives/edgar/data/19617/000089109211007615/e46154_424b2.pdf

Prospectus supplement dated November  14, 2011: http://www.sec.gov/Archives/edgar/data/19617/000089109211007578/e46180_424b2.pdf

Prospectus dated November  14, 2011: http://www.sec.gov/Archives/edgar/data/19617/000089109211007568/e46179_424b2.pdf

The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free (800) 869-3326.